InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions

Arnaud Bourdin, Gerard Criner, Gilles Devouassoux, Mark Dransfield, David M.G. Halpin, MeiLan K. Han, C. Elaine Jones, Ravi Kalhan, Peter Lange, Sally Lettis, David A. Lipson, David A. Lomas, José M. Echave-Sustaeta María-Tomé, Neil Martin, Fernando J. Martinez, Holly Quasny, Lynda Sail, Thomas M. Siler, Dave Singh, Byron Thomashow, Henrik Watz, Robert Wise, Nicola A. Hanania

Open source

DOI: 10.15326/jcopdf.2020.0158
Published: 2021
Container: Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
Publisher: COPD Foundation
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.15326/jcopdf.2020.0158,
  title = {InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions},
  author = {Arnaud Bourdin and Gerard Criner and Gilles Devouassoux and Mark Dransfield and David M.G. Halpin and MeiLan K. Han and C. Elaine Jones and Ravi Kalhan and Peter Lange and Sally Lettis and David A. Lipson and David A. Lomas and José M. Echave-Sustaeta María-Tomé and Neil Martin and Fernando J. Martinez and Holly Quasny and Lynda Sail and Thomas M. Siler and Dave Singh and Byron Thomashow and Henrik Watz and Robert Wise and Nicola A. Hanania},
  year = {2021},
  journal = {Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation},
  doi = {10.15326/jcopdf.2020.0158},
  url = {https://doi.org/10.15326/jcopdf.2020.0158}
}

RIS

TY  - JOUR
TI  - InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions
AU  - Arnaud Bourdin
AU  - Gerard Criner
AU  - Gilles Devouassoux
AU  - Mark Dransfield
AU  - David M.G. Halpin
AU  - MeiLan K. Han
AU  - C. Elaine Jones
AU  - Ravi Kalhan
AU  - Peter Lange
AU  - Sally Lettis
AU  - David A. Lipson
AU  - David A. Lomas
AU  - José M. Echave-Sustaeta María-Tomé
AU  - Neil Martin
AU  - Fernando J. Martinez
AU  - Holly Quasny
AU  - Lynda Sail
AU  - Thomas M. Siler
AU  - Dave Singh
AU  - Byron Thomashow
AU  - Henrik Watz
AU  - Robert Wise
AU  - Nicola A. Hanania
PY  - 2021
JO  - Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
DO  - 10.15326/jcopdf.2020.0158
UR  - https://doi.org/10.15326/jcopdf.2020.0158
ER  -

APA

Bourdin, A., Criner, G., Devouassoux, G., Dransfield, M., Halpin, D. M., Han, M. K., Jones, C. E., Kalhan, R., Lange, P., Lettis, S., Lipson, D. A., Lomas, D. A., María-Tomé, J. M. E., Martin, N., Martinez, F. J., Quasny, H., Sail, L., Siler, T. M., Singh, D., Thomashow, B., Watz, H., Wise, R., & Hanania, N. A. (2021). InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation. https://doi.org/10.15326/jcopdf.2020.0158

Source records

crossref · retrieved 2026-09-26T05:56:57.058Z